IMPRA Carboflo Grafts...A revolution in surface dynamics

Prosthetic materials are sufficiently different from the body's natural composition, causing the immune system to respond with platelet activity that leads to platelet adhesion, and thrombus deposition. This can frequently lead to occlusion and eventual prosthetic failure. IMPRA's ePTFE grafts are chemically inert and physiologically bio-compatible to minimize prosthetic rejection. ¹⁵

Carbon is used because it has demonstrated a lack of reactivity, even with blood products, in the field of vascular prosthesis. Studies suggest that carbon impregnated grafts may have fewer complications and improved primary and secondary patency rates compared to standard ePTFE grafts. ¹⁵

Carbon graft studies in animals have shown a statistically significant increase in thrombus free surface area, reduced platelet accumulation and increased patency rates. Prospective randomized trials for our carbon platform grafts are ongoing to validate these very encouraging results. ¹⁵

Impra, Inc., 1625 West Third Street P.O. Box 1740, Tempe, AZ 85280-1740. Tel: 480-894-9515; Fax: 480-966-7062.